|Bid||0.00 x 1800|
|Ask||0.00 x 3100|
|Day's Range||53.59 - 54.21|
|52 Week Range||36.15 - 64.94|
|Beta (5Y Monthly)||0.21|
|PE Ratio (TTM)||56.85|
|Forward Dividend & Yield||1.40 (2.63%)|
|Ex-Dividend Date||Aug 13, 2020|
|1y Target Est||N/A|
While Moderna CEO Stephane Bancel said his company's vaccine remains effective against coronavirus variants, a reoccurring booster shot could be likely.
Dr. Shereef Elnahal — CEO of University Hospital and former NJ DOH Commissioner — joins Yahoo Finance Live to discuss the latest developments on the coronavirus vaccination front, and what the government needs to do on a federal level to get communities of color to trust the medical establishment to boost inoculation.
Johnson & Johnson is expected soon to release test results for its coronavirus vaccine in a move that could rock vaccine stocks Pfizer and Moderna. Pfizer and Moderna have authorized drugs.